Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.98 +0.03 (+3.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Net Shares Issued and Repurchased (2010 - 2026)

Updated

Analysis

Lineage Cell Therapeutics (LCTX) Net Shares Issued and Repurchased (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,139.85 Bn 1,108.44 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 634.68 Bn 554.54 Bn 17.30 Bn -966.00 Mn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn -9.00 Mn
4 Merck 354.57 Bn 308.95 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 300.14 Bn 264.13 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 263.08 Bn 236.77 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.91 Bn 193.31 Bn 7.24 Bn -
8 Gilead Sciences 193.96 Bn 168.15 Bn 6.22 Bn -346.00 Mn
9 Pfizer 170.07 Bn 116.71 Bn 10.94 Bn -
10 Lineage Cell Therapeutics 246.43 Mn 45.95 Mn - 6,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,000.00
Mar 31, 2026 5.62 Mn
Dec 31, 2025 763,000.00
Sep 30, 2025 806,000.00
Sep 30, 2024 10,000.00
Jun 30, 2024 87,000.00
Mar 31, 2024 132,000.00
Dec 31, 2023 -6.63 Mn
Sep 30, 2023 844,000.00
Jun 30, 2023 5.82 Mn
Mar 31, 2023 51,000.00
Dec 31, 2022 131,000.00
Sep 30, 2022 972,000.00
Jun 30, 2022 106,000.00
Mar 31, 2022 529,000.00
Dec 31, 2021 974,000.00
Sep 30, 2021 3.75 Mn
Jun 30, 2021 11.31 Mn
Mar 31, 2021 20.98 Mn
Dec 31, 2020 -19.50 Mn
API Access

Lineage Cell Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=LCTX&period=max&api_key=YOUR_API_KEY